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Abstract
This report describes a measles outbreak in a rural town in south-east Queensland and presents the results of a
vaccine effectiveness (VE) study performed during this outbreak. It is important to assess the effectiveness of a
vaccine in an outbreak to determine if the outbreak is due to failure of the vaccine or failure to vaccinate. There
were 44 cases of measles amongst local residents, which represents a notification rate of 396.7 per 100,000
population. Case investigations identified a group of people who had been exposed to measles at a seminar. The
attack rate for the seminar cohort was 18% (11/61). This presented an opportunity to conduct a VE study using
data about children aged less than 16 years who attended the seminar. In this cohort of 23 attendees, all 7 children
who had not received any measles vaccinations became cases whilst the 6 who were fully vaccinated for their age
according to NHMRC guidelines were protected from measles illness. Although there were insufficient fully
vaccinated cohort members to reliably estimate VE for this group, the vaccine was 84.6% (95% CI: 15.0-99.7%)
effective for those who had received at least one validated dose of vaccine. Despite the sample size limitations, the
results support the view that failure to vaccinate rather than vaccine failure contributed to the high infection rate in 
the seminar cohort. Commun Dis Intell 1999;23:240-245.
Introduction
On 9 September 1997, a case of measles in a resident of
a rural town in south-east Queensland was notified to
Queensland Health. Serologically confirmed cases of
measles had already been reported from a neighbouring
town. By 15 September 7 measles notifications had been
received. Investigation of these cases revealed that some
had attended a local education seminar on 28 August. 
Investigation of the education seminar cohort identified an
opportunity to assess the effectiveness of the measles
vaccine. Assessing the effectiveness of a vaccine in an
outbreak is important to determine if the outbreak is due to 
failure of the vaccine or failure to vaccinate. Vaccine
efficacy  is usually determined under controlled conditions
prior to licensing, however the effectiveness of a vaccine
under normal (field) conditions may vary and should be
assessed when the opportunity arises. Vaccines may fail
due to incorrect storage and administration of the vaccine,
drug interference or the age at vaccination. Vaccine
effectiveness may vary in different populations.1
Establishing that a vaccine is effective during an outbreak
provides support for continuing efforts to improve
vaccination coverage levels and may allow the appraisal of 
current vaccination strategies. 
This report describes a measles outbreak in a rural town in 
south-east Queensland during 1997 and provides the
results of a vaccine effectiveness (VE) study. The
relationship of this outbreak to the state-wide outbreak is
also discussed.
Methods
Case definitions
The NHMRC measles case definitions for national
surveillance and a confirmed case2 (Box) were used to
define a case as being notifiable to the Queensland
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Box. Measles case definitions for notification to
the Queensland Notifiable Diseases
Registry2
Measles case definition for national surveillance
An illness characterised by all of the following
features:
(a) a generalised maculopapular rash lasting three
or more days; and 
(b) a fever exceeding 38.3°C; and 
(c) cough or coryza or conjunctivitis or Koplik spots.
Measles confirmed case definition
A person with signs and symptoms consistent with
measles and any one of the following: 
(a) measles virus detected in an appropriate
specimen; or
(b) the presence of measles specific IgM antibody;
or 
(c) a fourfold rise in measles antibody titre in sera
obtained at least two weeks apart; or 
(d) history of contact with a laboratory confirmed
case.
Notifiable Diseases Registry (NODS). A presumptive case
was defined as having an illness characterised by a
morbilliform rash, cough, and fever present at the time of
rash onset.2  
Notified cases with onset dates between 15 August and
31 December 1997 were considered part of the state-wide
outbreak. This time period was chosen because 15 August 
was the onset date of the first notified case in 1997 from
the town where this outbreak was first recognised, and the
number of State notifications returned to pre-outbreak
levels by 31 December. Cases considered part of the local 
outbreak were those with onset dates during the outbreak
who resided in the rural Queensland town, or were linked
to the education seminar. 
Outbreak notification rates were calculated using the 1996
census population supplied by the Australian Bureau of
Statistics. The distributions of local cases by age, sex,
date of onset, statistical local area of residency, and
method of diagnosis (clinical or laboratory confirmed) were 
determined.
Active case finding
All possible measles cases reported to the Central
Queensland Public Health Unit outbreak investigation
team were questioned about whether they had the
symptoms and signs that defined a presumptive or
notifiable case. Cases identified as being presumptive or
notifiable were asked about their contact with other people
during the period 1 day prior to developing signs of
measles to 4 days after developing a rash. This period was 
defined as the infectious period of a case.3  Individuals who 
had been in contact with an infectious case were
interviewed to determine whether they had the symptoms
and signs of measles. Presumptive or notifiable cases
were also questioned about their contact with other people 
in the incubation period 7 to 18 days prior to developing
signs of measles infection.3 People identified as having
had contact with a case during this period were then
interviewed about whether they had the symptoms and
signs of measles. Serological confirmation was
recommended for presumptive cases that did not have
incubation periods consistent with contact with an
infectious case, or when clinical symptoms did not conform 
to those used to define a notifiable case. Notifiable cases
identified by these active case finding methods were
allocated to one of the case types described in Table 1. 
Vaccine effectiveness study 
The cohort
Interviews with presumptive and notifiable primary cases
about their attendance at any gatherings during their
defined infectious period identified 11 cases who had
attended the education seminar. Investigation of these
cases identified one person who had coryzal symptoms
and conjunctivitis at the seminar and developed a rash the
next day. This case was therefore defined as being the
probable source case for the seminar cohort. 
The education seminar was investigated further to identify
a suitable cohort for performing a VE study. Details about
the seminar were obtained from the seminar coordinator.
The seminar was in a hall and there were two sessions
with a tea break in between. The first session ran from
2 p.m. until approximately 5.30 p.m. and the second ran
from 7 p.m. until 9 p.m. A list of people who attended the
education seminar was constructed by the seminar
coordinator and telephone interviews were conducted with
available attendees. Seminar attendees, or a parent of an
attendee, were questioned at least 18 days after the
seminar (that is, after the defined incubation period for
exposure to an infectious case at the seminar). Questions
were asked about attendance at each of the seminar
sessions, the attendees’ age, their measles vaccination
status, and whether they had the symptoms and signs that 
defined a presumptive or notifiable case. Attendees were
also asked if they could provide the names of any other
attendees in order to establish the completeness of the
attendance list. The interviews established that the
probable source case only attended the afternoon session
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Table 1. Case definitions used during the
investigation of a measles outbreak in
a rural Queensland town, and at an
education seminar in that town, 
15 August - 31 December 1997
Type of case Definition
Primary case A presumptive or notifiable
case. +
Secondary case As for a primary case, and 
had an incubation period
#
consistent with exposure to an
infectious* primary case. 
Probable source case As for a primary case, and 
whilst infectious,* they had
contact with a primary case, and 
this contact was within the time
frame for the incubation period#
of the primary case.
Probable source case
linked to the seminar
As for a primary case, and 
attended the seminar whilst
infectious.*
Primary case linked to
the seminar
As for a primary case, and 
attended the seminar, and
had an incubation period
between 
7 and 18 days after the seminar.
Secondary case linked to 
the seminar
As for a secondary case, and 
their primary case attended the
seminar.
Primary case indirectly
linked to the seminar
As for a primary case linked to
seminar, except
a family member (not the case)
attended the seminar.
Secondary case indirectly 
linked to the seminar
As for a primary case, and
had an incubation period#
consistent with exposure to an
infectious* primary case
indirectly linked to the seminar.
+ See Box for definitions.
# The incubation period was defined as between 7 and 18 days after
contact with an infectious case.
3
of the seminar and all primary cases linked to the seminar
also attended this session. Therefore, attendees of the
afternoon session of the seminar were a suitable cohort to
perform a VE study.
The age distribution of attendees at the afternoon session
of the seminar fell into two categories; children (aged
between 2 and 15 years), and adults (aged at least
30 years). Vaccine effectiveness calculations were
performed only for the children. Due to the measles
vaccine not being widely available in Australia until 1970,
adults aged at least 30 years are unlikely to be vaccinated
against measles and most would be immune due to past
exposure to the disease. 4 Since vaccination status and
disease risk in the adult group are likely to depend on
whether an individual has had past exposure to measles,
VE calculations including this group would give spuriously
low results.1 The attendee thought to be the source of
infection for the seminar cohort was excluded from the VE
study as they were not at risk of infection at the seminar.
Attendees with an unknown age, unknown vaccination
status, or a history of measles were also excluded (as
recommended by Orenstein, Bernier and Hinman1 ). 
Determining the vaccination status
Measles vaccination dates were determined by asking
parents of children who attended the seminar to read out
the vaccination dates entered in childhood immunisation
books. If a vaccination date could not be provided, consent 
to access the child’s general practitioner and council
records was requested. For the purposes of this study, a
vaccination was considered to be ‘validated’ if the
vaccination date could be obtained from any of the above
sources. The vaccination status for children indicating they 
had a prior history of measles or who were not vaccinated
was not confirmed. Children were defined to be ‘fully
vaccinated’ if they had received all vaccinations
recommended for their age5 (that is, children aged
between 1 and 9 years required one dose of measles
vaccine and children aged 10 years or over required two
doses to be defined as fully vaccinated). 
Vaccine effectiveness (VE) was calculated using the
following formula:1
VE(%)={(ARU-ARV)/ARU} x 100
where ARU=attack rate in the unvaccinated
and  ARV=attack rate in the vaccinated
Exact 95% Confidence Intervals for the VE estimates were 
calculated using STATA.6  All other analyses were
performed using Epi Info 6.04b.
7
Results
The outbreak
Forty-six cases of measles were notified as part of the
local outbreak (Figure 1). Two cases were visiting the area 
to attend the education seminar and 44 cases were local
residents. This represents a notification rate for the area of 
396.7 per 100,000 population (44/11,092). The local
notification rate was 64 times the outbreak rate for
Queensland (6.2/100,000 population).
During the outbreak period, more notifications were from
this town than from any other area. Local cases accounted 
for 21% (44/208) of the State’s outbreak notifications.
From this town, and a neighbouring town where the
outbreak was first recognised, the outbreak appeared to
spread across Queensland and interstate. This outbreak
was the largest in Queensland since the epidemic of 1993
and 1994 (Figure 2).
Eighteen measles notifications associated with the local
outbreak were linked to the education seminar and
28 cases were local residents who were not linked to the
seminar (Figure 1). Of the 18 cases linked to the seminar,
one case was the defined probable source case for the
seminar cohort, 11 were primary cases who had attended
the seminar, 4 were secondary cases linked to the
seminar, and 2 cases occurred in siblings whose well
parents had attended the seminar. One of these siblings
became ill 10 days after the seminar and was therefore a
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Figure 1. Measles notifications from a rural
Queensland town and notifications linked
to an education seminar in that town, by
week of onset, 15 August-31 December
1997
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Figure 2. Measles notifications for Queensland by
month of onset, January 1991 to February
1998
primary case indirectly linked to the seminar. The other
sibling was a secondary case indirectly linked to the
seminar. 
The probable source case for cases linked to the
education seminar was an unvaccinated child who went to
school in the town where the state-wide outbreak was first
identified. Other cases had previously been identified who
went to the same school. The source of infection for the
28 cases who were not linked to the education seminar is
unknown.
The age range for notified cases associated with the local
outbreak was 11 months to 34 years (median age
9 years). The number of notified cases generally
decreased with increasing age (Figure 3). Only 3 cases
were aged 1 year or younger. However, over half (54.3%)
of the notified cases were aged less than 10 years.
Thirty-nine out of the 44 local cases (88.6%) were aged
less than 20 years. The notification rate for this age group
was 1,090 per 100,000 population (39/3,579). There were
slightly more male notifications (M:F ratio 1.2:1).
Ten of the 46 cases (21.7%) associated with the local
outbreak were serologically confirmed, 2 of whom were
primary cases linked to the education seminar. Two of the
3 children aged 1 year or younger were serologically
confirmed.
The vaccine effectiveness study
The education seminar cohort
Sixty-two people were identified as having attended the
afternoon session of the education seminar. The names of
57 attendees were on the list of attendees provided. Five
extra attendees were identified by interviewing the listed
attendees. Information was available to determine the
disease status for all 62 seminar attendees. Excluding the
probable source case for the seminar cohort, the measles
attack rate was 18% (11/61). Of the 61 attendees exposed 
to the probable source case, 27 were defined as children
and 26 as adults (Figure 4). Eight attendees (12.9%)
refused to answer questions about their vaccination status
and age.
Of the 12 cases that had attended the seminar, only 7 had
been notified. The other 5 (41.7%) were identified by the
case investigation methods. Similarly, of the 6 secondary
cases linked to the seminar, 5 (83.3%) were identified by
the case investigation methods. 
The vaccine effectiveness study cohort
Of the 27 seminar attendees who were known to be
children and could have been exposed to measles at the
seminar, 3 gave a history of past infection with measles
and 1 child’s vaccination status was unknown (Table 2). 
The VE study cohort consisted of 23 attendees excluding
the 4 cases noted above. Of these attendees, 15 had
received one dose of measles vaccine and one had
received two doses. Thirteen of these 17 doses (76.5%)
were supported by the report of a vaccination date. The
date of vaccination was provided by the parent (8/13),
doctor (2/13) or the council (3/13).
In this cohort, all children who had not received any
vaccinations against measles (n=7) became cases, whilst
those who were fully vaccinated (n=6) were protected from 
disease. However, the small sample size of this
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Table 2. Vaccination status of children who
attended the education seminar by age
group 
Age group 1-9 years
10-15
years
Not vaccinated 5 2
History of measles 0 3
1 dose of measles vaccine
(% validated#)
5
(100%)
10
(70%)
2 doses of measles vaccine 0 1*
Unknown vaccination status 1 0
Total 11 16
# Validated = vaccination date provided by parent, doctor or council
comparison meant that the VE could not be estimated with 
any precision. For children who had received at least one
dose of measles vaccine, the point estimate VE was
81.3% (Table 3). When considering only validated doses,
the VE was 84.6%. There were insufficient cohort
members to stratify VE calculations by age.
Discussion
The outbreak
The outbreak notification rate in this town was high,
especially compared to rates for the rest of Queensland.
The rate is still likely to be an underestimate of the true
incidence. A large proportion of cases associated with the
education seminar were only identified by active case
finding during the investigation. Reasons for the high rates
in this town compared to the rest of Queensland are
unclear. Data recorded on the Queensland vaccination
register does not suggest that vaccination coverage levels
for local children are lower than for the rest of the State
(assuming the completeness of the vaccination register is
consistent across Queensland). However, the vaccination
register only provides vaccination coverage levels for
children up to the age of 2 years at present, therefore
population coverage levels cannot be determined. For
children aged 2 years or younger, the available vaccination 
coverage levels do indicate a degree of protection which is 
consistent with there being few local cases in this age
group. Prior to the outbreak, only one measles notification
had been received from this town since notifications were
first recorded on the NODS data base in 1991. If
notifications are equated to the disease incidence and
hence to exposure, past exposure is likely to be minimal,
which may explain the high local rates during this
outbreak. 
Local cases were distributed evenly among children aged
less than 10 years. This is unlike the age distribution of
national notifications for 19968 and State notifications
during the outbreak, where the most susceptible age group 
was infants too young to be vaccinated. Locally, infants
may have been under-represented as contacts with the
virus, especially at the education seminar which was for
school aged children and their parents. The seminar was
the most likely source of measles infection for a significant
proportion (23.9%) of the local outbreak cases.
Transmission of measles at the seminar was probably by
airborne droplet nuclei.9 As the measles virus is known to
be viable for several hours in droplet form,9 people who
attend the same room within 2 hours of an infectious
patient are considered ‘at risk’ of infection.2 Therefore the
high attack rate amongst afternoon seminar attendees is
not unexpected. Transmission also occurred indirectly to
one child whose well parents had attended the seminar.
This child may have been infected via contact with articles
freshly soiled with nasal or throat secretions containing the 
measles virus.3  
Vaccine effectiveness 
The results of this study support the view that the measles
vaccine was effective in preventing infection in the study
cohort. All children who attended the education seminar
and were fully vaccinated were protected against disease.
In addition, the point estimates of VE for children having
received at least one dose of vaccine are consistent with
the findings of other VE studies10,11  that indicate that the
vaccine was effective in other settings. However, the
outbreak investigation could only identify a small cohort to
determine the VE, hence the VE estimates have wide
confidence intervals due to sample size limitations. The
inability to obtain precise VE estimates highlights one of
the difficulties encountered when trying to estimate VE
during an outbreak. Despite these limitations, it was
important to have performed the study as the results do
not suggest the vaccine failed and provide support for
ongoing efforts to improve vaccination coverage. 
Selection and misclassification biases can affect VE
estimates. Problems with the sensitivity and specificity of
the case definition, case ascertainment, validity of
vaccination and disease histories, comparability of
vaccinated and unvaccinated cohort members, and non
participation can bias the VE estimate. Vaccine
effectiveness calculations using the seminar cohort
minimise many of the biases that can be encountered
when estimating VE. 
The definitions used to define a notifiable case were
applied to all cohort members equally by asking each
attendee, or their parent, whether they had the symptoms
and signs that defined a presumptive or notifiable measles
case. Two primary cases linked to the seminar were
serologically confirmed. These two measures should have
minimised misclassification of the disease status of cohort
members. All known seminar attendees were followed for
a time that would have identified the cases in this group.
Therefore unequal case ascertainment is unlikely to affect
the VE estimates. It is possible that not all attendees were
identified, and the effect this would have on the VE
estimates is unknown. This possibility was minimised by
obtaining a list of attendees and asking identified
attendees if they knew anyone else who attended. Only
one VE cohort member had an unknown vaccination
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Table 3. Measles vaccine effectiveness for children who attended the education seminar
Comparison Attack rate in vaccinated Attack rate in unvaccinated
Vaccine effectiveness 
% (95% CI+)
Received at least one dose vs never
vaccinated 3/16 7/7 81.3 (17.0-98.8)
Received at least one validated dose*
vs never vaccinated 2/13 7/7 84.6 (15.0-99.7)
* Validated = vaccination date provided by parent, doctor or council
+ CI = Confidence Interval
status, further minimising the possibility of non
participation bias. Eight attendees were excluded because
they refused to provide information about their age and
vaccination status. Orenstein, Bernier and Hinman
recommend these unknowns be excluded as it is difficult to 
predict how they would distribute themselves with regard
to vaccination status.1
The VE estimates are unlikely to be affected by differences 
in past exposure to measles between vaccinated and
unvaccinated cohort members. Firstly, cohort members
with a stated history of measles were excluded regardless
of vaccination status. Secondly, as previously discussed,
past exposure is likely to be minimal in the age groups
used for the calculations (assuming most children have
been long term residents of the area). Exposure during the 
current outbreak is also relatively uniform as all attendees
were in the same hall as the source case for a similar
amount of time.
A high proportion of vaccinations could be validated by
report of a vaccination date. Council and general
practitioner records are likely to be accurate, and would
not be biased by a knowledge of the attendee’s disease
status. Parental recall has been found to be an unreliable
method of determining vaccination status.12 To minimise
recall bias, parents were asked to read out the dates of
vaccination from written records. Similar methods have
been used in previous Australian studies10,11 and it is
unlikely that parents would fabricate a vaccination date.
However the validity of this method remains unproven. No
attempt was made to validate a history of measles or
vaccination records for VE cohort members stating they
had not been vaccinated. Therefore the results of this
study need to be interpreted with caution. Some members
who stated they were unvaccinated may have been
vaccinated, and this would lead to a biased estimate of VE 
if their reported vaccination status was biased by whether
they were a case. 
Conclusion
This outbreak investigation identified an opportunity to
assess the effectiveness of the measles vaccine under
field conditions. There is an ongoing need to assess
vaccine effectiveness in order to establish that a vaccine is 
effective in a given situation, and to provide support for
efforts to improve vaccination coverage levels. This
vaccine effectiveness study supports the view that failure
to vaccinate rather than vaccine failure contributed to the
high infection rate in the education seminar cohort.
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